CA2673579C - Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages - Google Patents

Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages Download PDF

Info

Publication number
CA2673579C
CA2673579C CA2673579A CA2673579A CA2673579C CA 2673579 C CA2673579 C CA 2673579C CA 2673579 A CA2673579 A CA 2673579A CA 2673579 A CA2673579 A CA 2673579A CA 2673579 C CA2673579 C CA 2673579C
Authority
CA
Canada
Prior art keywords
bacteriophage
bacteriophages
protein
modified
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2673579A
Other languages
English (en)
French (fr)
Other versions
CA2673579A1 (fr
Inventor
Francois Iris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phaxiam Therapeutics SA
Original Assignee
Pherecydes Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherecydes Pharma SA filed Critical Pherecydes Pharma SA
Publication of CA2673579A1 publication Critical patent/CA2673579A1/fr
Application granted granted Critical
Publication of CA2673579C publication Critical patent/CA2673579C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
CA2673579A 2006-12-20 2007-12-18 Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages Active CA2673579C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0655721 2006-12-20
FR0655721A FR2910492B1 (fr) 2006-12-20 2006-12-20 Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages
PCT/FR2007/002101 WO2008093009A2 (fr) 2006-12-20 2007-12-18 Procédé de préparation de bactériophages modifiés par insertion de séquences aléatoires dans les protéines de ciblage desdits bactériophages

Publications (2)

Publication Number Publication Date
CA2673579A1 CA2673579A1 (fr) 2008-08-07
CA2673579C true CA2673579C (fr) 2019-04-09

Family

ID=38293109

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2673579A Active CA2673579C (fr) 2006-12-20 2007-12-18 Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages

Country Status (7)

Country Link
US (1) US9315803B2 (https=)
EP (2) EP2653536A1 (https=)
JP (1) JP2010512774A (https=)
AU (1) AU2007346006B2 (https=)
CA (1) CA2673579C (https=)
FR (1) FR2910492B1 (https=)
WO (1) WO2008093009A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945049B1 (fr) 2009-04-30 2013-10-04 Pherecydes Pharma Modification du genome d'un bacteriophage lytique par immobilisation dudit bacteriophage dans sa bacterie hote
WO2017174809A1 (en) * 2016-04-08 2017-10-12 Phico Therapeutics Ltd Modifying bacteriophage
CN112823206B (zh) * 2018-10-17 2024-04-16 深圳华大生命科学研究院 从细菌全基因组序列中挖掘温和型噬菌体的方法、装置和存储介质
US11724057B2 (en) 2019-12-16 2023-08-15 Melissa H. Egts Protective, sanitary, securable nasal cannula cover
USD942002S1 (en) 2019-12-16 2022-01-25 Melissa H. Egts Nasal cannula cover
DE102024113842A1 (de) * 2024-05-16 2025-11-20 bifa Umweltinstitut GmbH Verfahren zur Verringerung der bakteriellen Last auf bzw. in einer Klimaanlage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270939B (it) * 1993-05-11 1997-05-26 Angeletti P Ist Richerche Bio Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
US6203986B1 (en) * 1998-10-22 2001-03-20 Robert H. Singer Visualization of RNA in living cells
CA2430501A1 (en) 2000-01-11 2001-07-19 Intralytix, Inc. Method for produce sanitation using bacteriophages
ES2252263T3 (es) * 2000-07-25 2006-05-16 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Bacteriofago que tiene una gama de hospedadores multiple.
GB0028130D0 (en) * 2000-11-17 2001-01-03 Phico Therapeutics Ltd Polypeptide and uses thereof
WO2006066224A2 (en) * 2004-12-14 2006-06-22 Yale University Virulence targeted antibiotics

Also Published As

Publication number Publication date
JP2010512774A (ja) 2010-04-30
US9315803B2 (en) 2016-04-19
WO2008093009A2 (fr) 2008-08-07
AU2007346006B2 (en) 2013-08-29
AU2007346006A1 (en) 2008-08-07
WO2008093009A8 (fr) 2009-07-16
CA2673579A1 (fr) 2008-08-07
WO2008093009A3 (fr) 2009-02-12
EP2097516A2 (fr) 2009-09-09
FR2910492A1 (fr) 2008-06-27
US20110027231A1 (en) 2011-02-03
FR2910492B1 (fr) 2013-02-15
EP2653536A1 (fr) 2013-10-23
EP2097516B1 (fr) 2012-11-14

Similar Documents

Publication Publication Date Title
Schneider Bacteriophage-mediated horizontal gene transfer: transduction
Kutter et al. Bacteriophages: biology and applications
CA2673579C (fr) Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages
JP2010512774A5 (https=)
CA2673004C (fr) Procede de diversification aleatoire d'une sequence genetique permettant de preserver l'identite de certains segments internes de ladite sequence genetique
Wang et al. Uncovering the determinants of model Escherichia coli strain C600 susceptibility and resistance to lytic T4-like and T7-like phage
CA2760275C (fr) Modification du genome d'un bacteriophage lytique par immobilisation dudit bacteriophage dans sa bacterie hote
Vincent et al. Would bacteriophages be a new old complement to antibiotics in aquaculture?
Parcey The Role of CRISPR-Mediated Phage Resistance in the Development of Phage-Based Biocontrol for Erwinia amylovora
Halmillawewa Isolation, characterization, and applications of rhizobiophages
Novik et al. Biodiversity conservation of phages and microbial populations
Mohammed Elucidating Mechanisms of Mycobacteriophage Butters Prophage-Mediated Defenses
Maguin Restriction-Modification and CRISPR-Cas systems: cooperation between innate and adaptive immunity in prokaryotes
O'Hara Interrogating the Complex Roles and Regulation of Vibrio cholerae Seventh Pandemic Islands
Khairnar et al. Bacteriophages Isolation From The Environment And Their Antimicrobial Therapeutic Potential
Chevallereau Comprehensive study of new virulent bacteriophages: from transcriptomic and mechanistic characterisations towards evolutionary perspectives
Alharby Isolation and characterization of a novel bacteriophage, ASC10, that lyses Francisella tularensis
Whittle Isolation and characterisation of four novel bacteriophages infecting clinically relevant PCR ribotypes of Clostridium difficile
Hutinet Homologous recombination in Bacteriophages, less fidelity for more exchanges
Chan Bacteriophages of marine Roseobacter
OWUSU-BINEY et al. GENETIC MATERIAL
Liu Parasite adaptations to dynamic hosts: Bordetella-phage and Bordetella-host interactions
WO2006106193A1 (fr) Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet

Legal Events

Date Code Title Description
EEER Examination request
H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250618

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251105